Table of contents
In this issue
p813 | doi:10.1038/nrd1540
Editorial: What price education?
p815 | doi:10.1038/nrd1539
News and Analysis
News
Hunt on to explain antidepressant risk
p817 | doi:10.1038/nrd1545
News
Unique collaboration finds the wizard of OZ
p818 | doi:10.1038/nrd1546
News
Calls for trial to assess genetic and environmental interactions in disease
p818 | doi:10.1038/nrd1547
News in Brief
Patent watch
Poster presentation can be printed publication
p820 | doi:10.1038/nrd1536
Patent watch
Primate stem cell patent denied in Europe
p820 | doi:10.1038/nrd1542
Patent watch
Written description not good enough
p820 | doi:10.1038/nrd1543
Patent primer
Written description
p821 | doi:10.1038/nrd1529
An Audience With
Jonathan K. C. Knowles discusses the impact of pharmacogenomics on market segmentation
p822 | doi:10.1038/nrd1541
From the analyst's couch
Killing the messenger
p823 | doi:10.1038/nrd1527
Fresh from the Pipeline
Pemetrexed disodium
p825 | doi:10.1038/nrd1528
Research Highlights
Chemistry: Chemical engineering in vivo
p827 | doi:10.1038/nrd1533
Pharmacogenomics: ABCs of drug resistance
p828 | doi:10.1038/nrd1531
Cardiovascular disease: Preventing the bubble bursting?
p828 | doi:10.1038/nrd1532
Apoptosis: Bid for death
p829 | doi:10.1038/nrd1530
Chemistry: Stabilizing staples
p830 | doi:10.1038/nrd1534
In brief
Lead discovery | High-throughput screening | Biotechnology | Tuberculosis
p830 | doi:10.1038/nrd1535
Reviews
Bradykinin receptor ligands: therapeutic perspectives
François Marceau & Domenico Regoli
p845 | doi:10.1038/nrd1522
Article series: A guide to drug discovery
A guide to drug discovery: The role of the medicinal chemist in drug discovery — then and now
Joseph G. Lombardino & John A. Lowe, III
p853 | doi:10.1038/nrd1523
Glycomics: a pathway to a class of new and improved therapeutics
Zachary Shriver, S. Raguram & Ram Sasisekharan
p863 | doi:10.1038/nrd1521
Prion diseases — close to effective therapy?
Neil R. Cashman & Byron Caughey
p874 | doi:10.1038/nrd1525
Perspective
Science and society
Strategies to facilitate the development of new contraceptives
Sharyl J. Nass & Jerome F. Strauss, III
p885 | doi:10.1038/nrd1526
